期刊文献+

宫颈癌患者淋巴结HPV16/18感染及血清鳞状细胞癌抗原检测的临床意义 被引量:4

The clinical significance of detection of HPV 16/18 in lymph nodes and squamous cell carcinoma antigen level in serum of cervical carcinoma patients
下载PDF
导出
摘要 目的:探讨宫颈癌患者淋巴结HPV16/18感染及术前血清鳞状细胞癌抗原(SCCA)水平与临床病理参数的相关性,以及宫颈分泌物及淋巴结中HPV16/18感染和术前血清SCCA水平三者之间的关系。方法:采用实时荧光定量PCR法检测35例宫颈癌患者的宫颈分泌物及淋巴结HPV16/18阳性率,同时用ELISA法检测术前血清SCCA水平。结果:宫颈癌患者宫颈分泌物及淋巴结HPV16/18阳性率分别为80%(28/35)和20%(7/35)。7例组织学阳性淋巴结及28例阴性淋巴结HPV16/18阳性率分别为85.71%(6/7)和3.57%(1/28)。SCCA阳性率为37.14%(13/35)。淋巴结HPV16/18阳性感染与术前SCCA水平相关(r=0.650,P<0.01),两者均与淋巴结转移、间质浸润深度及脉管累及有关(P<0.05),而和宫颈分泌物HPV16/18阳性感染无关(P>0.05)。结论:HPV16/18在组织学阳性淋巴结中感染率高,与宫颈癌患者淋巴结转移密切相关。而阴性淋巴结中的HPV16/18检出提示微转移。术前SCCA水平与淋巴结转移相关。 Objective:To investigate HPV16/18 infection in lymph nodes in cervical carcinoma and the relationship among preoperative serum level of squamous cell carcinoma antigen(SCCA),HPV16/18 infection in cervical secretion and pathological parameters. Methods:We detected the positive rate of HPV16/18 in lymph nodes and secretion of 35 cervical carcinoma patients by real-time quantitative polymerase chain reaction.Preoperative serum SCCA was detected by Enzyme-linked immunosorbent assay.Results:The positive rate of HPV16/18 in cervical secretion was 80%(28/35) and that in lymph nodes was 20%(7/35).The positive rate of HPV16/18 in lymph nodes with metastases was 85.71%(6/7)as compared with that of 3.57%(1/28) in the other patients without metastases.The positive rate of serum SCCA was 37.14%(13/35).HPV16/18 in positive lymph nodes was related to preoperative serum SCCA(r=0.650,P0.01).Both HPV16/18 positive in lymph nodes and SCCA were associated with lymph-node metastasis,depth of stromal invasion and lymph-vascular space invasion(P0.05).There were no statistical relationship between HPV16/18 in lymph nodes,preoperative level of SCCA and HPV16/18 in cervical secretion.Conclusions:A high infection rate of HPV16/18 in positive lymph nodes and preoperative SCCA are closely retlated to lymph-node metastasis in cervical carcinoma patients,while the detection of HPV16/18 in negative nodes may be an indication for tumor micrometastasis.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第7期523-526,共4页 Progress in Obstetrics and Gynecology
基金 江西省卫生厅科研基金资助项目(No:20071123)
关键词 宫颈肿瘤 人乳头瘤病毒 鳞状细胞癌抗原 淋巴结转移 Cervical neoplasms Human papillomavirus Squamous cell carcinoma antigen Lymph-node metastasis
  • 相关文献

参考文献8

  • 1Cheng X, Cai SM, Li ZT. The research advance of micrometastasis in patients with cervical carcinoma[ J]. Foreign Med Sci Oncol Sect ,2005,32:711-713.
  • 2Lukaszuk K, Liss J, Wozniak I, et al. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study [ J ]. Clin Pathol,2004,57:472-476.
  • 3Slama J, Drazd'akova M, Fischerova D, et al. Detection of HPV DNA in lymph nodes in early stages cervical cancers [ J]. Ceska Gynekol,2008,73:217-221.
  • 4孙颖,刘国炳,余艳红.盆腔淋巴结HPV-DNA检出率与早期宫颈癌临床转移的关系[J].南方医科大学学报,2008,28(5):796-798. 被引量:10
  • 5de Bruijn HW, Duk TM, vaner Zee AG,et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix[ J]. Tumour Biol, 1998,19:505-516.
  • 6Kim YT, Yoon BS, Kim JW, et al. Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix[ J ]. Int J Gynaecol Obstet,2005,91:47-52.
  • 7熊樱,梁立治,郑敏,魏梅,沈扬.鳞状细胞癌抗原与子宫颈鳞状细胞癌的临床病理特征及预后的关系[J].中华妇产科杂志,2007,42(1):29-33. 被引量:36
  • 8Kotowicz B, Fuksiewicz M, Kowalska M, et al. The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients [ J ]. Int J Gynecol Cancer, 2008,18 : 1279-1284.

二级参考文献18

  • 1荆结线,邵淑丽,田保国,韩存芝,赵先文,杜丽丽,张中书.宫颈癌SCCAg检测及其临床意义[J].中国肿瘤临床,2005,32(21):1242-1244. 被引量:13
  • 2Yazigi R,Munoz AK,Richardson B,et al.Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer.Gynecol Oncol,1991,41:135-138.
  • 3Rose PG,Baker S,Fournier L,et al.Serum squamous cell carcinoma antigen levels in invasive cervical cancer:prediction of response and recurrence.Am J Obstet Gynecol,1993,168:942-946.
  • 4Duk JM,Groenier KH,de Bruijn HW,et al.Pretreatment serum squamous cell carcinoma antigen:a newly identified prognostic factor in early-stage cervical carcinoma.J Clin Oncol,1996,14:111-118.
  • 5丸尾猛 吉村茂树.子宮頚癌と腫瘍マーカー[J].産婦人科治療,1999,79:65-70.
  • 6Takeshima N,Hirai Y,Katase K,et al.The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.Gynecol Oncol,1998,68:263-266.
  • 7Peters WA 3rd,Liu PY,Barrett RJ 2nd,et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol,2000,18:1606-1613.
  • 8Bosch FX, Lorincz A, Mtmoz N, et al. The causal relation between human papillomavirus and cervical cancer [J]. J Clin Pathol, 2002, 55(4): 244-65.
  • 9Jacobs MV, de Roda Husman AM, van den Brule AJ, et al. Groupspecific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes[J]. J Clin Microbiol, 1995, 33 (4): 901-5.
  • 10Remmerbach TW, Brinckmann UG, Hemprich A, et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5^+/6^+ primer sets[J].J Clin Virol, 2004, 30(4): 302-8.

共引文献43

同被引文献31

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部